• Nenhum resultado encontrado

Arq. NeuroPsiquiatr. vol.71 número6

N/A
N/A
Protected

Academic year: 2018

Share "Arq. NeuroPsiquiatr. vol.71 número6"

Copied!
1
0
0

Texto

(1)

418

OPINION

DOI: 10.1590/0004-282X20130053

Dear Editors,

We read with interest the manuscript published by Fernandes et al.1 As stated by Asplund2, stroke mortality is an equation between incidence (a marker of primary preven-tion) and 30-day case-fatality proportion (a marker of hos-pital quality of care). In MONICA study, stroke events from 39 populations, each of about 500,000 people, were recorded over 10 years. Some populations showed a decrease in mor-tality, two-thirds due to case-fatality reduction and one-third due to incidence reduction. he manuscript from Lotufo’s group deserves attention by showing the early case-fatality in three diferent hospitals in three Brazilian cities. In fact, 7-day case-fatality was recently implemented as an indicator to measure early stroke death (by neurological causes) because

important clinical decisions are made in the irst week after hospital admission3.

Up to 10 days after an ischemic stroke, Fernandes et al. reported a case-fatality rate of 7% (57/804; 95%CI 5.3–8.0). In 11 stroke centers in Canada, from 2003 to 2005, Saposnik et al. found 6.9% of case-fatality rate for 7 days3. Despite these data came from hospitalar series and could have a selection bias (did not capture deaths occurred before hospital admis-sion), they translate the “real world” and should be used as a benchmark to compare stroke centers with others. In Brazil, this can be very useful once last March, 2012 the Ministry of Health launched the Brazilian Stroke Act, which encompass-es lysis for stroke centers and more stroke units countrywide4.

Norberto Cabral Anderson R. R. Gonçalves

References

1. Fernandes TG, Goulart AC, Campos TF, et al. Early stroke case-fatality rates in three hospital registries in the Northeast and Southeast of Brazil. Arq Neuropsiquiatr 2012;70:869-873.

2. Asplund K. What MONICA told us about stroke. Lancet Neurol 2005;4:64-68.

3. Saposnik G, Hill MD, O’Donnell M, Fang J, Hachinski V, Kapral MK; Registry

of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 2008;39:2318-2324. 4. Ministério da Saúde (BR). Protocolos clínicos e diretrizes terapêuticas.

[cited at 2012 Jul 14] Available at: http://portal.saude.gov.br/portal/ arquivos/pdf/pcdt_trombolise_avc_isq_agudo.pdf

Correspondence: Norberto Luiz Cabral; Rua Plácido Olimpio de Oliveira 1244; 89202-451 Joinville SC - Brasil; E-mail: nlcabral@terra.com.br

Conflict of interest:There is no conflict of interest to declare.

Referências

Documentos relacionados

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical

scarceness of empirical evidence relating unilateral stroke, post-stroke depression and cognitive impairment following this comorbidity, the present article aims to investigate

The aim of the present study was to verify the use of the 30 minutes velocity (VT-30), stroke rate (SR), stroke length (SL) and stroke index (SI), obtained in T-30 test, as

ABSTRACT: Objective: The study evaluated the trend of hospitalization for ischemic stroke (HIS) and its hospital mortality in Brazil over the last 15 years as well as the impact of

The socio-demographic data (gender, age, educa- tional level, and marital status), acute stroke in- formation (stroke subtype, onset of neurological symptoms, and pre-stroke

Interesting, although the stroke is existed in cancerous patient, it is usually not considered in cancer therapy.. If stroke occurs, a more complex scenario can be expected and

It was only in 2012 that the Brazilian Ministry of Health produced and published important policies for the public national health sys - tem (SUS) for people with

Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial ibrillation in the International Stroke Trial. Audebert